Early outcomes of Pyrocardan (R) implants for trapeziometacarpal osteoarthritis

T. M. A. S. Lauwers*, K. Brouwers, H. Staal, L. T. Hoekstra, R. R. W. J. van der Hulst

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The aim of this retrospective study was to assess the early outcomes of trapeziometacarpal osteoarthritis treatment using Pyrocardan (R) implants in patients with early Eaton (stage I and II) osteoarthritis. We analyzed the results of 27 patients, with a median age of 59 years (range, 34-78 years) and a mean follow-up of 24 months (range, 12-41). The level of satisfaction was assessed using a postoperative questionnaire. Twenty patients mentioned having improvements in their activities of daily living, 20 patients were satisfied with the outcomes of surgery, and 19 patients would consider undergoing the procedure a second time. Five patients needed reoperation for complications, including persistent pain, grinding, or implant dislocation. Pyrocardan (R) implants may be a valuable temporary therapy as more conventional arthroplasty techniques are still feasible in case of failure. However, multicenter randomized controlled trials with a longer follow-up are needed to assess the long-term outcomes.
Original languageEnglish
Pages (from-to)407-412
JournalHand Surgery and Rehabilitation
Issue number6
Publication statusPublished - Dec 2016


  • Trapeziometacarpal osteoarthritis
  • Pyrocarbon
  • Arthroplasty
  • Pyrocardan (R) implant


Dive into the research topics of 'Early outcomes of Pyrocardan (R) implants for trapeziometacarpal osteoarthritis'. Together they form a unique fingerprint.

Cite this